https://www.prnewswire.com/news-releases/biosion-announces-phase-ii-study-start-for-anti-tslp-mab-bsi-045b-in-atopic-dermatitis-adamant-301889071.html
/PRNewswire/ -- Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced the phase 2 study initiation for the...
phase ii studyannouncesstartantitslp
https://www.healio.com/news/pulmonology/20260102/qa-longacting-antitslp-antibody-for-severe-asthma-moves-into-phase-3
Two replicate phase 3 trials of GB-0895, an anti-thymic stromal lymphopoietin antibody, are enrolling adults and adolescents with severe asthma, according to a...
long actingphasetrialantitslp
https://tslp.org/
Transition Services Liaison Project I am a Family Member/Student I am a Professional TSLP Events State Resources About Us The TSLP Mission: To be commited to...
transition servicestslpliaisonproject
https://dataintelo.com/report/global-tslp-monoclonal-antibody-market
The global TSLP Monoclonal Antibody market size was valued at approximately USD 1.2 billion in 2023 and is projected to reach USD 4.5 billion by 2032, growing...
monoclonal antibodymarket reportglobal forecasttslp
https://www.pharmaceutical-technology.com/data-insights/bicycle-therapeutics-gets-grant-for-high-affinity-peptide-binders-for-thymic-stromal-lymphopoietin-tslp/
Discover the groundbreaking patent by Bicycle Therapeutics Plc for high-affinity TSLP binders, revolutionizing treatment for TSLP-mediated diseases. Explore...
high affinitybicycletherapeuticsplcpatent